(Q70177471)

English

The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers

scientific article published on 01 August 1983

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

author name string

S. B. Reele

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

O. V. Miller

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

C. Spillers

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

R. R. Gorman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6316420

26 September 2023

publication date

1 August 1983

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0090698083900965?httpAccept=text/xml

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

https://api.elsevier.com/content/article/PII:0090698083900965?httpAccept=text/plain

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

287-302

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

1

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

2

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1α on the rat gastric mucosa in vivo and in vitro

3

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Effects of prostacyclin (PGI2), 6-oxo-PGF1 alpha and PGE2 on sympathetic nerve function in mesenteric arteries and veins of the rabbit in vitro

4

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Actions of prostacyclin (PGI2) on adrenergic neuroeffector transmission in the rabbit kidney

5

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man

6

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Haemodynamic changes induced by prostacyclin in man.

7

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels

8

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Effects of intravenous infusion of prostacyclin (PGI2) in man

9

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

10

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin infusion during cardiopulmonary bypass in man.

11

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin administration during cardiopulmonary bypass in man.

12

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure

13

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Salutary effects of prostacyclin in endotoxic shock

14

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin reversal of lethal endotoxemia in dogs

15

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease

17

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin therapy in peripheral arterial disease

18

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease

19

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?

20

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Increased platelet activity after termination of prostacyclin infusion into man

21

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man

25

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)

26

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Identifiers

10.1016/0090-6980(83)90096-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70177471&oldid=1981764318"